Author:
Chu Yongli,Wang Yanlin,Zhang Guanghua,Chen Haibin,Dowdy Sean C.,Xiong Yuning,Liu Fengming,Zhang Run,Li Jinping,Jiang Shi-Wen
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine
Reference74 articles.
1. Sitruk-Ware R, Plu-Bureau G (1999) Progestins and cancer. Gynecol Endocrinol 13(Suppl 4):3–9
2. Markman M (2005) Hormonal therapy of endometrial cancer. Eur J Cancer 41:673–675
3. Pike MC, Pearce CL, Wu AH (2004) Prevention of cancers of the breast, endometrium and ovary. Oncogene 23:6379–6391
4. Podratz KC, O’Brien PC, Malkasian GD Jr, Decker DG, Jefferies JA, Edmonson JH (1985) Effects of progestational agents in treatment of endometrial carcinoma. Obstet Gynecol 66:106–110
5. Figueroa-Casas PR, Ettinger B, Delgado E, Javkin A, Vieder C (2001) Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy. Menopause 8:420–423
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献